HSBC agrees to US$2 billion deal to sell Singapore insurance branch to Allianz
AdvertisementBanking & financeBusinessCompanies HSBC agrees to US$2 billion deal to sell Singapore insurance branch to Allianz Allianz is set to…
Why the spectre of ‘climate black swan’ events is haunting global investors
AdvertisementBanking & financeBusinessBanking & Finance Why the spectre of ‘climate black swan’ events is haunting global investors As the threat…
Zhipu shares surge 37% as firm builds giant data centre powered by Chinese chips
AdvertisementZhipu AITechBig Tech Zhipu shares surge 37% as firm builds giant data centre powered by Chinese chips The Chinese AI…
‘Payback’: why China’s world-beating car industry faces plunging sales at home
AdvertisementChina manufacturingEconomyChina Economy ‘Payback’: why China’s world-beating car industry faces plunging sales at home Chinese car brands have suffered a…
BrainCo unveils ‘brain-controlled’ robot platform at China’s World AI Conference
AdvertisementArtificial intelligenceTechTech Trends BrainCo unveils ‘brain-controlled’ robot platform at China’s World AI Conference Hangzhou-based firm says users can control robots…
Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals
AdvertisementBanking & financeBusinessChina Business Mainland China funds increase stakes in Hong Kong biotech amid surge of licensing deals Analysts say…
Chinese medical device makers push into Europe as anti-corruption squeeze bites at home
AdvertisementChina’s private sectorBusinessChina Business Chinese medical device makers push into Europe as anti-corruption squeeze bites at home Chinese medical device…
Hong Kong banks sweeten mortgage rebates as competition heats up amid property rebound
AdvertisementHong Kong propertyBusiness Hong Kong banks sweeten mortgage rebates as competition heats up amid property rebound Mortgage battle intensifies as…
China AI drug-design deals swell as US scrutiny mounts
AdvertisementChina’s private sectorBusinessChina Business China AI drug-design deals swell as US scrutiny mounts Global pharmaceutical firms are tapping into Chinese…